Skye Bioscience accelerates nimacimab clinical trial timeline with early enrollment and extended treatment period
Discover Skye Bioscience's progress on nimacimab with early trial enrollment, extended treatment protocols, and robust regulatory plans.
ETF Daily News14d
Charles Schwab Investment Management Inc. Grows Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)
Bio-Techne Price Performance Bio-Techne stock opened at $64.37 on Monday. Bio-Techne Co. has a 12-month low of $58.98 and a 12-month high of $85.57. The stock has a market cap of $10.18 billion, a ...
ETF Daily News14d
Bio-Techne Co. (NASDAQ:TECH) Shares Bought by Keybank National Association OH
Bio-Techne Price Performance Shares of Bio-Techne stock opened at $64.37 on Monday. The company has a quick ratio of 2.77, a current ratio of 3.94 and a debt-to-equity ratio of 0.14. Bio-Techne Co ...
ETF Daily News14d
Firsthand Technology Value Fund (NASDAQ:SVVC) Now Covered by StockNews.com
10 Stocks to Sell NOW! 3 Stocks to DOUBLE This ... It seeks to invest in pre-IPO companies. The fund also seeks to make investments in companies with operating histories that are unprofitable ...
Business Insider14d
Q32 Bio presents results from SIGNAL-AA Part 2a trial of bempikibart
Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on QTTB: Q32 Bio NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Nasdaq14d
This Nvidia-Backed IPO Grew 737% Last Year and Is About to Go Public: What Investors Should Know About CoreWeave
at least upon the IPO's unveiling. Don’t miss this second chance at a potentially lucrative opportunity Ever feel like you missed the boat in buying the most successful stocks? Then you’ll ...
Nasdaq14d
If You'd Bought 1 Share of VeriSign at Its IPO, Here's How Many Shares You Would Own Now
Internet domain registration specialist VeriSign (NASDAQ: VRSN) has been quite the ... That's because after that IPO, VeriSign split its stock twice in the following year. In both June and ...
Yahoo Finance15d
Nuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to Analysts
In this article, we are going to take a look at where Nuvation Bio Inc. (NYSE:NUVB) stands against the other NYSE penny stocks. President Trump’s tariffs on Canada and Mexico went live on March ...
Seeking Alpha15d
StubHub targets raising more than $1B in IPO this year
StubHub previously considered an IPO in 2024, but it was delayed due ... Inc., it was rebranded as StubHub in 2003. In 2007, eBay (NASDAQ:EBAY) acquired StubHub for $310 million, significantly ...
Nasdaq15d
Q32 Bio Presents Additional Results From Phase 2a Trial Of Bempikibart In Alopecia Areata
(RTTNews) - Q32 Bio Inc. (QTTB) announced additional results ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in ...
ETF Daily News16d
Wedbush Comments on Passage Bio’s Q1 Earnings (NASDAQ:PASG)
Passage Bio, Inc. (NASDAQ:PASG – Free Report) – Equities research analysts at Wedbush lifted their Q1 2025 earnings per share (EPS) estimates for shares of Passage Bio in a research report ...
Nasdaq16d
Tevogen Bio's CIO Mittul Mehta Discusses AI Innovations in Biotech at Proskauer Panel
Tevogen.AI emphasizes innovation in precision medicine. Mittul Mehta, Chief Information Officer at Tevogen Bio, participated in an AI discussion panel titled "Attuned AI: Shaping AI to Empower ...